The ischemic environment drive s microglia and macrophage function

Frontiers in Neurology

Volumn 6, Issue MAR, 2015, Pages

  Fumagalli, Stefano ^a,b   Perego, Carlo ^a   Pischiutta, Francesca ^a   Zanier, Elisa R ^a   De Simoni, Maria Grazia ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Acute brain injury; Cell morphology; Macrophages; Microglia; Neuroinflammation; Phenotypical polarization

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ANAEROBIC METABOLISM; ARTICLE; BONE MARROW CELL; BRAIN FUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; CELL ACTIVITY; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CEREBROVASCULAR ACCIDENT; CHEMOTAXIS; ENVIRONMENTAL CHANGE; HOMEOSTASIS; HUMAN; HYPOXIA; INNATE IMMUNITY; MACROPHAGE FUNCTION; MICROGLIA; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHENOTYPE; POLARIZATION; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

EID: 84926507821     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00081     Document Type: Article

References (223)

1. Wilson EH, Weninger W, Hunter CA. Trafficking of immune cells in the central nervous system. J Clin Invest (2010) 120:1368-1379. doi:10.1172/JCI41911
2. Lampron A, Elali A, Rivest S. Innate immunity in the CNS: redefining the relationship between the CNS and Its environment. Neuron (2013) 78:214-232. doi:10.1016/j.neuron.2013.04.005
3. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan W-B. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci (2005) 8:752-758. doi:10.1038/nn1472
4. Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res (2005) 81:302-313. doi:10.1002/jnr.20562
5. Salter MW, Beggs S. Sublime microglia: expanding roles for the guardians of the CNS. Cell (2014) 158:15-24. doi:10.1016/j.cell.2014.06.008
6. Ransohoff RM, Cardona AE. The myeloid cells of the central nervous system parenchyma. Nature (2010) 468:253-262. doi:10.1038/nature09615
7. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, Dieli F, Ghisletti S, Natoli G, De Baetselier P, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A (2009) 106:14978-14983. doi:10.1073/pnas.0809784106
8. Perego C, Fumagalli S, De Simoni M-G. Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation (2011) 8:174. doi:10.1186/1742-2094-8-174
9. Derecki NC, Katzmarski N, Kipnis J, Meyer-Luehmann M. Microglia as a critical player in both developmental and late-life CNS pathologies. Acta Neuropathol (Berl) (2014) 128:333-345. doi:10.1007/s00401-014-1321-z
10. Sica A, Melillo G, Varesio L. Hypoxia: a double-edged sword of immunity. J Mol Med Berl Ger (2011) 89:657-665. doi:10.1007/s00109-011-0724-8
11. Xu H, Chen M, Mayer EJ, Forrester JV, Dick AD. Turnover of resident retinal microglia in the normal adult mouse. Glia (2007) 55:1189-1198. doi:10.1002/glia.20535
12. Hanisch U-K, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci (2007) 10:1387-1394. doi:10.1038/nn1997
13. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol (2011) 11:775-787. doi:10.1038/nri3086
14. Girard S, Brough D, Lopez-Castejon G, Giles J, Rothwell NJ, Allan SM. Microglia and macrophages differentially modulate cell death after brain injury caused by oxygen-glucose deprivation in organotypic brain slices. Glia (2013) doi:10.1002/glia.22478
15. Gundra UM, Girgis NM, Ruckerl D, J enkins S, Ward LN, Kurtz ZD, Wiens KE, Tang MS, Basu-Roy U, Mansukhani A, et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood (2014) 123:e110-e122. doi:10.1182/blood-2013-08-520619
16. Brouns R, De Deyn PP. The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg (2009) 111:483-495. doi:10.1016/j.clineuro.2009.04.001
17. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron (2010) 67:181-198. doi:10.1016/j.neuron.2010.07.002
18. Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat Neurosci (2007) 10:1377-1386. doi:10.1038/nn2004
19. Gimeno-Bayón J, López-López A, Rodríguez MJ, Mahy N. Glucose pathways adaptation supports acquisition of activated microglia phenotype. J Neurosci Res (2014) 92:723-731. doi:10.1002/jnr.23356
20. Atkinson SJ, Hosford MA, Molitoris BA. Mechanism of actin polymerization in cellular ATP depletion. J Biol Chem (2004) 279:5194-5199. doi:10.1074/jbc.M306973200
21. Masuda T, Croom D, Hida H, Kirov SA. Capillary blood flow around microglial somata determines dynamics of microglial processes in ischemic conditions. Glia (2011) 59:1744- 1753. doi:10.1002/glia.21220
22. Yang Z, Zhao T-Z, Zou Y-J, Zhang JH, Feng H. Hypoxia Induces autophagic cell death through hypoxia-inducible factor 1a in microglia. PloS One (2014) 9:e96509. doi:10.1371/journal.pone.0096509
23. Shi H. Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem (2009) 16:4593-4600.
24. Singh N, Sharma G, Mishra V. Hypoxia inducible factor-1: its potential role in cerebral ischemia. Cell Mol Neurobiol (2012) 32:491-507. doi:10.1007/s10571-012-9803-9
25. Demougeot C, Van Hoecke M, Bertrand N, Prigent-Tessier A, Mossiat C, Beley A, Marie C. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. J Pharmacol Exp Ther (2004) 311:1080-1087. doi:10.1124/jpet.104.072744
26. Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC. Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci Off J Soc Neurosci (2007) 27:6320-6332. doi:10.1523/JNEUROSCI.0449-07.2007
27. Chen C, Hu Q, Yan J, Yang X, Shi X, Lei J, Chen L, Huang H, Han J, Zhang JH, et al. Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis (2009) 33:509-517. doi:10.1016/j.nbd.2008.12.010
28. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, et al. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci Off J Soc Neurosci (2005) 25:4099- 4107. doi:10.1523/JNEUROSCI.4555-04.2005
29. Sheldon RA, Osredkar D, Lee CL, Jiang X, Mu D, Ferriero D M. HIF-1 alpha-deficient mice have increased brain injury after neonatal hypoxia-ischemia. Dev Neurosci (2009) 31:452-458. doi:10.1159/000232563
30. Riboldi E, Porta C, Morlacchi S, Viola A, Mantovani A, Sica A. Hypoxia-mediated regulation of macrophage functions in pathophysiology. Int Immunol (2013) 25:67-75. doi:10.1093/intimm/dxs110
31. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell (2012) 148:399-408. doi:10.1016/j.cell.2012.01.021
32. Taylor CT, Cummins EP. The role of NF-kappaB in hypoxia-induced gene expression. Ann N Y Acad Sci (2009) 1177:178-184. doi:10.1111/j.1749-6632.2009.05024.x
33. Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 112:645-657.
34. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest (2005) 115:1806-1815. doi:10.1172/JCI23865
35. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med (2004) 10:858-864. doi:10.1038/nm1075
36. Martin C, Bridger GJ, Rankin SM. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro. Br J Haematol (2006) 134:326-329. doi:10.1111/j.1365-2141.2006.06181.x
37. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med (2003) 198:1391-1402. doi:10.1084/jem.20030267
38. Kabadi SV, Stoica BA, Byrnes KR, Hanscom M, Loane DJ, Faden AI. Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab (2012) 32:137-149. doi:10.1038/jcbfm.2011.117
39. Zhan X, Kim C, Sharp FR. Very brief focal ischemia simulating transient ischemic attacks (TIAs) can injure brain and induce Hsp70 protein. Brain Res (2008) 1234:183-197. doi:10.1016/j.brainres.2008.07.094
40. Fumagalli S, Perego C, Ortolano F, De Simoni M-G. CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia (2013) 61:827-842. doi:10.1002/glia.22474
41. Zanier ER, Fumagalli S, Perego C, Pischiutta F, De Simoni M-G. Shape descriptors of the "never resting" microglia in three different acute brain injury models in mice. Intensive Care Med Exp (2015) 3:7. doi:10.1186/s40635-015-0039-0
42. Chu HX, Kim HA, Lee S, Moore JP, Chan CT, Vinh A, Gelderblom M, Arumugam TV, Broughton BRS, Drummond GR, et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab (2014) 34:450-459. doi:10.1038/jcbfm.2013.217
43. Zhou W, Liesz A, Bauer H, Sommer C, Lahrmann B, Valous N, Grabe N, Veltkamp R. Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol Zurich Switz (2013) 23:34-44. doi:10.1111/j.1750-3639.2012.00614.x
44. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, Wu PM, Doykan CE, Lin J, Cotleur AC, et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med (2014) 211:1533-1549. doi:10.1084/jem.20132477
45. Varvel NH, Grathwohl SA, Baumann F, Liebig C, Bosch A, Brawek B, Thal DR, Charo IF, Heppner FL, Aguzzi A, et al. Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc Natl Acad Sci U S A (2012) 109:18150- 18155. doi:10.1073/pnas.1210150109
46. Simard AR, Soulet D, Gowing G, Julien J-P, Rivest S. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron (2006) 49:489-502. doi:10.1016/j.neuron.2006.01.022
47. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, Waisman A, Rülicke T, Prinz M, Priller J, et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med (2005) 11:146-152. doi:10.1038/nm1177
48. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, Allan SM. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab (2007) 27:1941-1953. doi:10.1038/sj.jcbfm.9600495
49. özen I, Deierborg T, Miharada K, Padel T, Englund E, Genové G, Paul G. Brain pericytes acquire a microglial phenotype after stroke. Acta Neuropathol (Berl) (2014) 128:381-396. doi:10.1007/s00401-014-1295-x
50. Del Zoppo GJ, Mabuchi T. Cerebral microvessel responses to focal ischemia. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab (2003) 23:879-894. doi:10.1097/01.WCB.0000078322.96027.78
51. Fumagalli S, Ortolano F, De Simoni M-G. A close look at brain dynamics: Cells and vessels seen by in vivo two-photon microscopy. Prog Neurobiol (2014) doi:10.1016/j.pneurobio.2014.06.005
52. Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, Deerinck TJ, Smirnoff DS, Bedard C, Hakozaki H, et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun (2012) 3:1227. doi:10.1038/ncomms2230
53. De la Rosa X, Cervera A, Kristoffersen AK, Valdés CP, Varma HM, Justicia C, Durduran T, Chamorro á, Planas AM. Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice. Stroke J Cereb Circ (2014) 45:1453-1459. doi:10.1161/STROKEAHA.113.004111
54. Thornton P, McColl BW, Greenhalgh A, Denes A, Allan SM, Rothwell NJ. Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood (2010) 115:3632-3639. doi:10.1182/blood-2009-11-252643
55. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature (2010) 468:232-243. doi:10.1038/nature09613
56. Perego C, Fumagalli S, De Simoni M-G. Three-dimensional confocal analysis of microglia/macrophage markers of polarization in experimental brain injury. J Vis Exp JoVE (2013) doi:10.3791/50605
57. Cunningham CL, Martínez-Cerdeño V, Noctor SC. Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci Off J Soc Neurosci (2013) 33:4216-4233. doi:10.1523/JNEUROSCI.3441-12.2013
58. Kettenmann H, Hanisch U-K, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev (2011) 91:461-553. doi:10.1152/physrev.00011.2010
59. Ohsawa K, Imai Y, Sasaki Y, Kohsaka S. Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem (2004) 88:844-856.
60. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe C-U, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke J Cereb Circ (2009) 40:1849-1857. doi:10.1161/STROKEAHA.108.534503
61. Gesuete R, Storini C, Fantin A, Stravalaci M, Zanier ER, Orsini F, Vietsch H, Mannesse MLM, Ziere B, Gobbi M, et al. Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol (2009) 66:332-342. doi:10.1002/ana.21740
62. Orsini F, Villa P, Parrella S, Zangari R, Zanier ER, Gesuete R, Stravalaci M, Fumagalli S, Ottria R, Reina JJ, et al. Targeting Mannose Binding Lectin Confers Long Lasting Protection with a Surprisingly Wide Therapeutic Window in Cerebral Ischemia. Circulation (2012) doi:10.1161/CIRCULATIONAHA.112.103051
63. Defaux A, Zurich M-G, Braissant O, Honegger P, Monnet-Tschudi F. Effects of the PPAR beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination. J Neuroinflammation (2009) 6:15. doi:10.1186/1742-2094-6-15
64. Xiang Z, Chen M, Ping J, Dunn P, Lv J, Jiao B, Burnstock G. Microglial morphology and its transformation after challenge by extracellular ATP in vitro. J Neurosci Res (2006) 83:91-101. doi:10.1002/jnr.20709
65. Lee JE, Liang KJ, Fariss RN, Wong WT. Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci (2008) 49:4169-4176. doi:10.1167/iovs.08-2076
66. Saederup N, Chan L, Lira SA, Charo IF. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions i n atherogenesis. Circulation (2008) 117:1642-1648. doi:10.1161/CIRCULATIONAHA.107.743872
67. Prinz M, Priller J. Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol (2010) 224:80-84. doi:10.1016/j.jneuroim.2010.05.015
68. Ingersoll MA, Platt AM, Potteaux S, Randolph GJ. Monocyte trafficking in acute and chronic inflammation. Trends Immunol (2011) 32:470-477. doi:10.1016/j.it.2011.05.001
69. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19:71-82.
70. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 317:666-670. doi:10.1126/science.1142883
71. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, et al. Identification of a unique TGF-ß-dependent molecular and functional signature in microglia. Nat Neurosci (2014) 17:131-143. doi:10.1038/nn.3599
72. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F, et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell (2014) 159:1327-1340. doi:10.1016/j.cell.2014.11.023
73. Block ML, Zecca L, Hong J-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci (2007) 8:57-69. doi:10.1038/nrn2038
74. Hanisch U-K. Microglia as a source and target of cytokines. Glia (2002) 40:140-155. doi:10.1002/glia.10161
75. Lalancette-Hébert M, Gowing G, Simard A, Weng YC, Kriz J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci Off J Soc Neurosci (2007) 27:2596-2605. doi:10.1523/JNEUROSCI.5360-06.2007
76. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K. Microglia provide neuroprotection after ischemia. FASEB J Off Publ Fed Am Soc Exp Biol (2006) 20:714-716. doi:10.1096/fj.05-4882fje
77. Nakajima K, Yamamoto S, Kohsaka S, Kurihara T. Neuronal stimulation leading to upregulation of glutamate transporter-1 (GLT-1) in rat microglia in vitro. Neurosci Lett (2008) 436:331-334. doi:10.1016/j.neulet.2008.03.058
78. Stoll G, Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol (1999) 58:233-247.
79. Thored P, Heldmann U, Gomes-Leal W, Gisler R, Darsalia V, Taneera J, Nygren JM, Jacobsen S-EW, Ekdahl CT, Kokaia Z, et al. Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia (2009) 57:835-849. doi:10.1002/glia.20810
80. Lu Y-Z, Lin C-H, Cheng F-C, Hsue h C-M. Molecular mechanisms responsible for microglia derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci Lett (2005) 373:159-164. doi:10.1016/j.neulet.2004.10.004
81. Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci Off J Soc Neurosci (1999) 19:1708-1716.
82. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P. Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol (2009) 210:3-12. doi:10.1016/j.jneuroim.2009.02.003
83. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 122:787-795. doi:10.1172/JCI59643
84. David S, Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci (2011) 12:388-399. doi:10.1038/nrn3053
85. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 25:677-686. doi:10.1016/j.it.2004.09.015
86. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 23:549-555.
87. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci J Virtual Libr (2008) 13:453-461.
88. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol Baltim Md 1950 (2006) 177:7303-7311.
89. Gordon S. Alternative activation of macrophages. Nat Rev Immunol (2003) 3:23-35. doi:10.1038/nri978
90. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K, Goerdt S. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol (2001) 53:386-392.
91. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol Baltim Md 1950 (2001) 167:6533-6544.
92. Raes G, Van den Bergh R, De Baetselier P, Ghassabeh GH, Scotton C, Locati M, Mantovani A, Sozzani S. Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J Immunol Baltim Md 1950 (2005) 174:6561; author reply 6561- 6562.
93. Scotton CJ, Martinez FO, Smelt MJ, Sironi M, Locati M, Mantovani A, Sozzani S. Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL- J Immunol Baltim Md 1950 (2005) 174:834-845.
94. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med (1992) 176:287-292.
95. Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet (2009) 18:482-496. doi:10.1093/hmg/ddn376
96. Anderson CF, Mosser DM. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol (2002) 72:101-106.
97. Anderson CF, Mosser DM. Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors. J Immunol Baltim Md 1950 (2002) 168:3697-3701.
98. Filardy AA, Pires DR, Nunes MP, Takiya CM, Freire-de-Lima CG, Ribeiro-Gomes FL, DosReis GA. Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages. J Immunol Baltim Md 1950 (2010) 185:2044-2050. doi:10.4049/jimmunol.1000017
99. Gea-Sorlí S, Guillamat R, Serrano-Mollar A, Closa D. Activation of lung macrophage subpopulations in experimental acute pancreatitis. J Pathol (2011) 223:417-424. doi:10.1002/path.2814
100. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen presenting cells. Immunity (1999) 10:137-142.
101. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem (1992) 267:23301-23308.
102. Valledor AF, Ricote M. Nuclear receptor signaling in macrophages. Biochem Pharmacol (2004) 67:201-212.
103. Butovsky O, Bukshpan S, Kunis G, Jung S, Schwartz M. Microglia can be induced by IFN gamma or IL-4 to express neural or dendritic-like markers. Mol Cell Neurosci (2007) 35:490-500. doi:10.1016/j.mcn.2007.04.009
104. Gee JM, Zierath D, Hadwin J, Savos A, Kalil A, Thullbery M, Becker KJ. Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp Transl Stroke Med (2009) 1:3. doi:10.1186/2040-7378-1-3
105. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol (2012) 34:43-62. doi:10.1007/s00281-011-0290-8
106. Galea J, Brough D. The role of inflammation and interleukin-1 in acute cerebrovascular disease. J Inflamm Res (2013) 6:121-128. doi:10.2147/JIR.S35629
107. Gertig U, Hanisch U-K. Microglial diversity by responses and responders. Front Cell Neurosci (2014) 8:101. doi:10.3389/fncel.2014.00101
108. Wang Y, Colonna M. Interkeukin- 34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells. Eur J Immunol (2014) 44:1575-1581. doi:10.1002/eji.201344365
109. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1996) 93:14833-14838.
110. Boscia F, D'Avanzo C, Pannaccione A, Secondo A, Casamassa A, Formisano L, Guida N, Scorziello A, Di Renzo G, Annunziato L. New roles of NCX in glial cells: activation of microglia in ischemia and differentiation of oligodendrocytes. Adv Exp Med Biol (2013) 961:307-316. doi:10.1007/978-1-4614-4756-6_26
111. Kierdorf K, Prinz M. Factors regulating microglia activation. Front Cell Neurosci (2013) 7:44. doi:10.3389/fncel.2013.00044
112. Awada R, Saulnier-Blache JS, Grès S, Bourdon E, Rondeau P, Parimisetty A, Orihuela R, Harry GJ, d' Hellencourt CL. Autotaxin downregulates LPS-induced microglia activation and pro-inflammatory cytokines production. J Cell Biochem (2014) 115:2123-2132. doi:10.1002/jcb.24889
113. Zhang Z, Zhang Z-Y, Wu Y, Schluesener HJ. Immunolocalization of Toll-like receptors 2 and 4 as well as their endogenous ligand, heat shock protein 70, in rat traumatic brain injury. Neuroimmunomodulation (2012) 19:10-19. doi:10.1159/000326771
114. Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron (2012) 74:691-705. doi:10.1016/j.neuron.2012.03.026
115. Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J Off Publ Fed Am Soc Exp Biol (2006) 20:670-682. doi:10.1096/fj.05-5106com
116. Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoist C. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol (2006) 7:284-292. doi:10.1038/ni1306
117. Galea I, Bechmann I, Perry VH. What is immune privilege (not)? Trends Immunol (2007) 28:12-18. doi:10.1016/j.it.2006.11.004
118. Taylor SE, Morganti-Kossmann C, Lifshitz J, Ziebell JM. Rod microglia: a morphological definition. PloS One (2014) 9:e97096. doi:10.1371/journal.pone.0097096
119. Kigerl KA, de Rivero Vaccari JP, Dietrich WD, Popovich PG, Keane RW. Pattern recognition receptors and central nervous system repair. Exp Neurol (2014) 258:5-16. doi:10.1016/j.expneurol.2014.01.001
120. Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Ooboshi H. Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J Neurochem (2012) 123 Suppl 2:29-38. doi:10.1111/j.1471-4159.2012.07941.x
121. Lawrence T, Natoli G. Transcriptional re gulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 11:750-761. doi:10.1038/nri3088
122. Gesuete R, Kohama SG, Stenzel-Poore MP. Toll-like receptors and ischemic brain injury. J Neuropathol Exp Neurol (2014) 73:378-386. doi:10.1097/NEN.0000000000000068
123. Griffiths MR, Gasque P, Neal JW. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J Neuropathol Exp Neurol (2009) 68:217-226. doi:10.1097/NEN.0b013e3181996688
124. Orsini F, De Blasio D, Zangari R, Zanier ER, De Simoni M-G. Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis. Front Cell Neurosci (2014) 8:380. doi:10.3389/fncel.2014.00380
125. Barratt-Due A, Pischke SE, Brekke O-L, Thorgersen EB, Nielsen EW, Espevik T, Huber-Lang M, Mollnes TE. Bride and groom in systemic inflammation--the bells ring for complement and Toll in cooperation. Immunobiology (2012) 217:1047-1056. doi:10.1016/j.imbio.2012.07.019
126. Hajishengallis G, Lambris JD. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol (2010) 31:154-163. doi:10.1016/j.it.2010.01.002
127. Benoit ME, Hernandez MX, Dinh ML, Benavente F, Vasquez O, Tenner AJ. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-ß neurotoxicity. J Biol Chem (2013) 288:654-665. doi:10.1074/jbc.M112.400168
128. Färber K, Cheung G, Mitchell D, Wallis R, Weihe E, Schwaeble W, Kettenmann H. C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation. J Neurosci Res (2009) 87:644-652. doi:10.1002/jnr.21875
129. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, et al. The classical complement cascade mediates CNS synapse elimination. Cell (2007) 131:1164-1178. doi:10.1016/j.cell.2007.10.036
130. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 11:889-896. doi:10.1038/ni.1937
131. Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, Pitman N, Mirchandani A, Rana B, van Rooijen N, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol Baltim Md 1950 (2009) 183:6469-6477. doi:10.4049/jimmunol.0901575
132. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci Off J Soc Neurosci (2009) 29:3974-3980. doi:10.1523/JNEUROSCI.4363-08.2009
133. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 53:527-552.
134. James G, Butt AM. P2Y and P2X purinoceptor mediated Ca2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol (2002) 447:247-260
135. Kobayashi K, Yamanaka H, Noguchi K. Expression of ATP receptors in the rat dorsal root ganglion and spinal cord. Anat Sci Int (2013) 88:10-16. doi:10.1007/s12565-012-0163-9
136. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S, Inoue K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature (2007) 446:1091-1095. doi:10.1038/nature05704
137. Gelosa P, Lecca D, Fumagalli M, Wypych D, Pignieri A, Cimino M, Verderio C, Enerbäck M, Nikookhesal E, Tremoli E, et al. Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab (2014) 34:979-988. doi:10.1038/jcbfm.2014.45
138. Koizumi S, Ohsawa K, Inoue K, Kohsaka S. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors. Glia (2013) 61:47-54. doi:10.1002/glia.22358
139. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol (2009) 29:1419-1423. doi:10.1161/ATVBAHA.108.180497
140. Zanier ER, Pischiutta F, Riganti L, Marchesi F, Turola E, Fumagalli S, Carlo Perego, Parotto E, Vinci P, Veglianese P, et al. Bone Marrow Mesenchymal Stromal Cells Drive Protective M2 Microglia Polarization After Brain Trauma. Neurother J Am Soc Exp Neurother (2014) doi:10.1007/s13311-014-0277-y
141. Gomes C, Ferreira R, George J, Sanches R, Rodrigues DI, Gonçalves N, Cunha RA. Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia. J Neuroinflammation (2013) 10:16. doi:10.1186/1742-2094-10-16
142. Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol (2014) 14:463-477. doi:10.1038/nri3705
143. Grinberg YY, Milton JG, Kraig RP. Spreading depression sends microglia on Lévy flights. PloS One (2011) 6:e19294. doi:10.1371/journal.pone.0019294
144. Hamann J, Koning N, Pouwels W, Ulfman LH, van Eijk M, Stacey M, Lin H-H, Gordon S, Kwakkenbos MJ. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor. Eur J Immunol (2007) 37:2797-2802. doi:10.1002/eji.200737553
145. Ifuku M, Färber K, Okuno Y, Yamakawa Y, Miyamoto T, Nolte C, Merrino VF, Kita S, Iwamoto T, Komuro I, et al. Bradykinin-induced microglial migration mediated by B1-bradykinin receptors depends on Ca2+ influx via reverse-mode activity of the Na+/Ca2+ exchanger. J Neurosci Off J Soc Neurosci (2007) 27:13065-13073. doi:10.1523/JNEUROSCI.3467-07.2007
146. Giunti D, Parodi B, Usai C, Vergani L, Casazza S, Bruzzone S, Mancardi G, Uccelli A. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells Dayt Ohio (2012) 30:2044-2053. doi:10.1002/stem.1174
147. Neumann J, Sauerzweig S, Rönicke R, Gunzer F, Dinkel K, Ullrich O, Gunzer M, Reymann KG. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J Neurosci Off J Soc Neurosci (2008) 28:5965-5975. doi:10.1523/JNEUROSCI.0060-08.2008
148. Neher JJ, Emmrich JV, Fricker M, Mander PK, Théry C, Brown GC. Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc Natl Acad Sci U S A (2013) 110:E4098-4107. doi:10.1073/pnas.1308679110
149. Brown GC, Neher JJ. Eaten alive! Cell death by primary phagocytosis: "phagoptosis." Trends Biochem Sci (2012) 37:325-332. doi:10.1016/j.tibs.2012.05.002
150. Grommes C, Lee CYD, Wilkinson BL, Jiang Q, Koenigsknecht-Talboo JL, Varnum B, Landreth GE. Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol (2008) 3:130-140. doi:10.1007/s11481-007-9090-2
151. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature (2002) 417:182-187. doi:10.1038/417182a
152. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature (2001) 411:207-211. doi:10.1038/35075603
153. Wu Y, Singh S, Georgescu M-M, Birge RB. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci (2005) 118:539-553. doi:10.1242/jcs.01632
154. De Beer MC, Zhao Z, Webb NR, van der Westhuyzen DR, de Villiers WJS. Lack of a direct role for macrosialin in oxidized LDL metabolism. J Lipid Res (2003) 44:674-685. doi:10.1194/jlr.M200444-JLR200
155. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 11:785-797. doi:10.1038/ni.1923
156. Vinet J, Weering HRJ van, Heinrich A, Kälin RE, Wegner A, Brouwer N, Heppner FL, Rooijen N van, Boddeke HWGM, Biber K. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflammation (2012) 9:27. doi:10.1186/1742-2094-9-27
157. Tan JL, Tien J, Pirone DM, Gray DS, Bhadriraju K, Chen CS. Cells lying on a bed of microneedles: an approach to isolate mechanical force. Proc Natl Acad Sci U S A (2003) 100:1484-1489. doi:10.1073/pnas.0235407100
158. McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci U S A (2013) 110:17253-17258. doi:10.1073/pnas.1308887110
159. Ziebell JM, Taylor SE, Cao T, Harrison JL, Lifshitz J. Rod microglia: elongation, alignment, and coupling to form trains across the somatosensory cortex after experimental diffuse brain injury. J Neuroinflammation (2012) 9:247. doi:10.1186/1742-2094-9-247
160. Cho BP, Song DY, Sugama S, Shin DH, Shi Mizu Y, Kim SS, Kim YS, Joh TH. Pathological dynamics of activated microglia following medial forebrain bundle transection. Glia (2006) 53:92-102. doi:10.1002/glia.20265
161. Lambertsen KL, Deierborg T, Gregersen R, Clausen BH, Wirenfeldt M, Nielsen HH, Dalmau I, Diemer NH, Dagnaes-Hansen F, Johansen FF, et al. Differences in origin of reactive microglia in bone marrow chimeric mouse and rat after transient global ischemia. J Neuropathol Exp Neurol (2011) 70:481-494. doi:10.1097/NEN.0b013e31821db3aa
162. Fenn AM, Gensel JC, Huang Y, Popovich PG, Lifshitz J, Godbout JP. Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia. Biol Psychiatry (2014) 76:575-584. doi:10.1016/j.biopsych.2013.10.014
163. Kondo S, Kohsaka S, Okabe S. Long-term changes of spine dynamics and microglia after transient peripheral immune response triggered by LPS in vivo. Mol Brain (2011) 4:27. doi:10.1186/1756-6606-4-27
164. Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, Raddassi K, Bronson RT, Khoury SJ. Elevated neuronal expression of CD200 protects Wlds mice from inflammation mediated neurodegeneration. Am J Pathol (2007) 170:1695-1712. doi:10.2353/ajpath.2007.060677
165. Neumann H, Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol (2007) 184:92-99. doi:10.1016/j.jneuroim.2006.11.032
166. Mott RT, Ait-Ghezala G, Town T, Mori T, Vendrame M, Zeng J, Ehrhart J, Mullan M, Tan J. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia (2004) 46:369-379. doi:10.1002/glia.20009
167. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain J Neurol (2009) 132:3342-3352. doi:10.1093/brain/awp300
168. Gahmberg CG, Tian L, Ning L, Nyman-Huttunen H. ICAM-5--a novel two-facetted adhesion molecule in the mammalian brain. Immunol Lett (2008) 117:131-135. doi:10.1016/j.imlet.2008.02.004
169. Limatola C, Ransohoff RM. Modulating neurotoxicity through CX3CL1/CX3CR1 signaling. Front Cell Neurosci (2014) 8:229. doi:10.3389/fncel.2014.00229
170. Vitkovic L, Maeda S, Sternberg E. Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation (2001) 9:295-312. doi:59387
171. Qian L, Wei S-J, Zhang D, Hu X, Xu Z, Wilson B, El-Benna J, Hong J-S, Flood PM. Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immunol Baltim Md 1950 (2008) 181:660-668.
172. Ludwig A, Weber C. Transmembrane chemokines: versatile "special agents" in vascular inflammation. Thromb Haemost (2007) 97:694-703.
173. Rogers JT, Morganti JM, Bachstetter A D, Hudson CE, Peters MM, Grimmig BA, Weeber EJ, Bickford PC, Gemma C. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci Off J Soc Neurosci (2011) 31:16241-16250. doi:10.1523/JNEUROSCI.3667-11.2011
174. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci (2006) 9:917-924. doi:10.1038/nn1715
175. Dénes A, Ferenczi S, Halász J, Környei Z, Kovács KJ. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab (2008) 28:1707-1721. doi:10.1038/jcbfm.2008.64
176. Corona AW, Huang Y, O'Connor JC, Dantzer R, Kelley KW, Popovich PG, Godbout JP. Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation (2010) 7:93. doi:10.1186/1742-2094-7-93
177. Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, Ransohoff RM, Popovich PG. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci Off J Soc Neurosci (2011) 31:9910-9922. doi:10.1523/JNEUROSCI.2114-11.2011
178. Bachstetter AD, Morganti JM, Jernberg J, Schlunk A, Mitchell SH, Brewster KW, Hudson CE, Cole MJ, Harrison JK, Bickford PC, et al. Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol Aging (2011) 32:2030-2044. doi:10.1016/j.neurobiolaging.2009.11.022
179. Tremblay M-É, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The role of microglia in the healthy brain. J Neurosci Off J Soc Neurosci (2011) 31:16064-16069. doi:10.1523/JNEUROSCI.4158-11.2011
180. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, Hartmann D, Fahrenholz F, Postina R, Matthews V, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood (2003) 102:1186-1195. doi:10.1182/blood-2002-12-3775
181. Lauro C, Catalano M, Trettel F, Mainiero F, Ciotti MT, Eusebi F, Limatola C. The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the beta1 integrin subunit. J Immunol Baltim Md 1950 (2006) 177:7599-7606.
182. Soriano SG, Amaravadi LS, Wang YF, Zhou H, Yu GX, Tonra JR, Fairchild-Huntress V, Fang Q, Dunmore JH, Huszar D, et al. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol (2002) 125:59-65.
183. Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E, Perego C, De Simoni M-G, Fredholm BB, Eusebi F, et al. CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci Off J Soc Neurosci (2011) 31:16327-16335. doi:10.1523/JNEUROSCI.3611-11.2011
184. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo J-L, Libby P, Weissleder R, Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 204:3037-3047. doi:10.1084/jem.20070885
185. Blomster LV, Brennan FH, Lao HW, Harle DW, Harvey AR, Ruitenberg MJ. Mobilisation of the splenic monocyte reservoir and peripheral CX3CR1 deficiency adversely affects recovery from spinal cord injury. Exp Neurol (2013) 247:226-240. doi:10.1016/j.expneurol.2013.05.002
186. Briones TL, Woods J, Wadowska M. Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling. J Neuroinflammation (2014) 11:13. doi:10.1186/1742-2094-11-13
187. Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J Neuroinflammation (2011) 8:9. doi:10.1186/1742-2094-8-9
188. Cho S-H, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L. CX3CR1 protein signaling modulates microglial activation and protects against plaque independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem (2011) 286:32713-32722. doi:10.1074/jbc.M111.254268
189. Zujovic V, Benavides J, Vigé X, Carter C, Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia (2000) 29:305-315.
190. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med (2011) 17:796-808. doi:10.1038/nm.2399
191. Hefendehl JK, Neher JJ, Sühs RB, Kohsaka S, Skodras A, Jucker M. Homeostatic and injury induced microglia behavior in the aging brain. Aging Cell (2013) doi:10.1111/acel.12149
192. Cohen M, Matcovitch O, David E, Barnett-Itzhaki Z, Keren-Shaul H, Blecher-Gonen R, Jaitin DA, Sica A, Amit I, Schwartz M. Chronic exposure to TGFß1 regulates myeloid cell inflammatory response in an IRF7-dependent manner. EMBO J (2014) doi:10.15252/embj.201489293
193. Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem (1993) 53:314-322. doi:10.1002/jcb.240530408
194. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 477:90-94. doi:10.1038/nature10357
195. Felton LM, Cunningham C, Rankine EL, Waters S, Boche D, Perry VH. MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease. Neurobiol Dis (2005) 20:283-295. doi:10.1016/j.nbd.2005.03.008
196. Henkel JS, Engelhardt JI, Siklós L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol (2004) 55:221-235. doi:10.1002/ana.10805
197. Sly LM, Krzesicki R F, Brashler JR, Buhl AE, McKinley DD, Carter DB, Chin JE. Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res Bull (2001) 56:581-588.
198. Sriram K, Miller DB, O'Callaghan JP. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem (2006) 96:706-718. doi:10.1111/j.1471-4159.2005.03566.x
199. Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia (2013) 61:71-90. doi:10.1002/glia.22350
200. Côté M, Poirier A-A, Aubé B, Jobin C, Lacroix S, Soulet D. Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson's disease. Brain Behav Immun (2015) doi:10.1016/j.bbi.2015.01.009
201. Gualtieri T, Cox DR. The delayed neurobehavioural sequelae of traumatic brain injury. Brain Inj BI (1991) 5:219-232.
202. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2006) 27:24-31. doi:10.1016/j.it.2005.11.006
203. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol (2000) 22:370-379. doi:10.1016/S0893-133X(99)00134-7
204. Liesz A, Hagmann S, Zschoche C, Adamek J, Zhou W, Sun L, Hug A, Zorn M, Dalpke A, Nawroth P, et al. The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke J Cereb Circ (2009) 40:2849-2858. doi:10.1161/STROKEAHA.109.549618
205. Fassbender K, Schneider S, Bertsch T, Schlueter D, Fatar M, Ragoschke A, Kühl S, Kischka U, Hennerici M. Temporal profile of release of interleukin-1beta in neurotrauma. Neurosci Lett (2000) 284:135-138.
206. Kossmann T, Hans VH, Imhof HG, Stocker R, Grob P, Trentz O, Morganti-Kossmann C. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock Augusta Ga (1995) 4:311-317.
207. Maier B, Schwerdtfeger K, Mautes A, Holanda M, Müller M, Steudel WI, Marzi I. Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock Augusta Ga (2001) 15:421-426.
208. Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WST, Nicoll J a. R. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int (2004) 146:97-104. doi:10.1016/j.forsciint.2004.06.027
209. Eckert MA, Vu Q, Xie K, Yu J, Liao W, Cramer SC, Zhao W. Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab (2013) 33:1322-1334. doi:10.1038/jcbfm.2013.91
210. Hegyi B, Környei Z, Ferenczi S , Fekete R, Kudlik G, Kovács KJ, Madarász E, Uher F. Regulation of mouse microglia activation and effector functions by bone marrow-derived mesenchymal stem cells. Stem Cells Dev (2014) 23:2600-2612. doi:10.1089/scd.2014.0088
211. Yan K, Zhang R, Sun C, Chen L, Li P, Liu Y, Peng L, Sun H, Qin K, Chen F, et al. Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation. PloS One (2013) 8:e84116. doi:10.1371/journal.pone.0084116
212. Rahmat Z, Jose S, Ramasamy R, Vidyadaran S. Reciprocal interactions of mouse bone marrow-derived mesenchymal stem cells and BV2 microglia after lipopolysaccharide stimulation. Stem Cell Res Ther (2013) 4:12. doi:10.1186/scrt160
213. Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol (2009) 37:1445-1453. doi:10.1016/j.exphem.2009.09.004
214. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 11:723-737. doi:10.1038/nri3073
215. Ohtaki H, Ylostalo JH, Foraker JE, Robinson AP, Reger RL, Shioda S, Prockop DJ. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A (2008) 105:14638-14643. doi:10.1073/pnas.0803670105
216. Nakajima H, Uchida K, Guerrero AR, Watanabe S, Sugita D, Takeura N, Yoshida A, Long G, Wright KT, Johnson WEB, et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma (2012) 29:1614-1625. doi:10.1089/neu.2011.2109
217. Zanier ER, Montinaro M, Vigano M, Villa P, Fumagalli S, Pischiutta F, Longhi L, Leoni ML, Rebulla P, Stocchetti N, et al. Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit Care Med (2011) 39:2501-2510. doi:10.1097/CCM.0b013e31822629ba
218. Tang Z, Gan Y, Liu Q, Yin J-X, Liu Q, Shi J, Shi F-D. CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke. J Neuroinflammation (2014) 11:26. doi:10.1186/1742-2094-11-26
219. Fuhrmann M, Bittner T, Jung CKE, Burgold S, Page RM, Mitteregger G, Haass C, LaFerla FM, Kretzschmar H, Herms J. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci (2010) 13:411-413. doi:10.1038/nn.2511
220. Lee S, Varvel NH, Konerth ME, Xu G, Cardona AE, Ransohoff RM, Lamb BT. CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol (2010) 177:2549-2562. doi:10.2353/ajpath.2010.100265
221. Liu Z, Condello C, Schain A, Harb R, Grutzendler J. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-ß phagocytosis. J Neurosci Off J Soc Neurosci (2010) 30:17091-17101. doi:10.1523/JNEUROSCI.4403-10.2010
222. Bhaskar K , Konerth M, Kokiko-Cochran ON, Cardona A, Ransohoff RM, Lamb BT. Regulation of tau pathology by the microglial fractalkine receptor. Neuron (2010) 68:19-31. doi:10.1016/j.neuron.2010.08.023
223. Madore C, Joffre C, Delpech JC, De Smedt-Peyrusse V, Aubert A, Coste L, Layé S, Nadjar A. Early morphofunctional plasticity of microglia in response to acute lipopolysaccharide. Brain Behav Immun (2013) 34:151-158. doi:10.1016/j.bbi.2013.08.008